| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 187 | 2022 |
| Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial CT Bramante, JB Buse, DM Liebovitz, JM Nicklas, MA Puskarich, K Cohen, ... The Lancet Infectious Diseases 23 (10), 1119-1129, 2023 | 78 | 2023 |
| Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles ER Lusczek, NE Ingraham, BS Karam, J Proper, L Siegel, ES Helgeson, ... Plos one 16 (3), e0248956, 2021 | 60 | 2021 |
| Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas A Toyama, L Siegel, AC Nelson, M Najmuddin, L Bu, R LaRue, C Henzler, ... Modern Pathology 32 (12), 1727-1733, 2019 | 44 | 2019 |
| Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up CT Bramante, JB Buse, D Liebovitz, J Nicklas, MA Puskarich, K Cohen, ... medRxiv, 2022 | 26 | 2022 |
| RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19 KD Wick, L Siegel, JD Neaton, C Oldmixon, J Lundgren, RL Dewar, ... JCI insight 7 (9), 2022 | 20 | 2022 |
| Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms CT Bramante, JL Proper, DR Boulware, AB Karger, T Murray, V Rao, ... Open Forum Infectious Diseases 9 (5), ofac066, 2022 | 20 | 2022 |
| Estimating the reference range from a meta‐analysis L Siegel, MH Murad, H Chu Research synthesis methods 12 (2), 148-160, 2021 | 20 | 2021 |
| Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial ACTIV-3/TICO Study Group* Annals of internal medicine 175 (9), 1266-1274, 2022 | 16 | 2022 |
| Morbidity and Mortality Trends of Pancreatitis: An Observational Study NE Ingraham, S King, J Proper, L Siegel, EJ Zolfaghari, TA Murray, ... Surgical infections 22 (10), 1021-1030, 2021 | 15 | 2021 |
| Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery DJ Douin, L Siegel, G Grandits, A Phillips, NR Aggarwal, J Baker, ... American journal of respiratory and critical care medicine 206 (6), 730-739, 2022 | 13 | 2022 |
| The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses Z Liu, FM Al Amer, M Xiao, C Xu, L Furuya-Kanamori, H Hong, L Siegel, ... BMC medicine 21 (1), 1-12, 2023 | 10 | 2023 |
| Outpatient treatment of COVID-19 and the development of long COVID Over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial C Bramante, JB Buse, D Liebovitz, J Nicklas, M Puskarich, KR Cohen, ... | 10 | 2023 |
| Review of clinical characteristics and laboratory findings of COVID-19 in children-Systematic review and Meta-analysis HK Kharoud, R Asim, L Siegel, L Chahal, GD Singh medRxiv, 2020.09. 23.20200410, 2020 | 9 | 2020 |
| Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial CT Bramante, KB Beckman, T Mehta, AB Karger, DJ Odde, CJ Tignanelli, ... medRxiv, 2023 | 8 | 2023 |
| Performance of Ventana SP263 PD‐L1 assay in endobronchial ultrasound guided‐fine‐needle aspiration derived non‐small‐cell lung carcinoma samples A Chauhan, L Siegel, R Freese, E Racila, J Stewart III, K Amin Diagnostic Cytopathology 49 (3), 355-362, 2021 | 8 | 2021 |
| Bayesian meta‐analysis using SAS PROC BGLIMM KW Rott, L Lin, JS Hodges, L Siegel, A Shi, Y Chen, H Chu Research Synthesis Methods 12 (6), 692-700, 2021 | 7 | 2021 |
| Predictors of Postacute Sequelae of COVID-19 Development and Rehabilitation: A Retrospective Study N Abdelwahab, NE Ingraham, N Nguyen, L Siegel, G Silverman, ... Archives of Physical Medicine and Rehabilitation 103 (10), 2001-2008, 2022 | 6 | 2022 |
| Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial DR Boulware, TA Murray, JL Proper, CJ Tignanelli, JB Buse, DM Liebovitz, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 5 | 2022 |
| A guide to estimating the reference range from a meta-analysis using aggregate or individual participant data L Siegel, MH Murad, RD Riley, F Bazerbachi, Z Wang, H Chu American journal of epidemiology 191 (5), 948-956, 2022 | 5 | 2022 |
Haitao ChuProfessor of Biostatistics, University of MinnesotaVerified email at umn.edu
